Conference Coverage

Ibrexafungerp effective against C. auris in two early case reports
Dhammika Navarathna is a Clinical Microbiologist, and Eric Rachut is a Pathologist, both in the Department of Pathology and Laboratory Medicine; Chetan Jinadatha is a Physician in the Infectious Diseases section, and Gagan Prakash is a Physician in the Department of Medicine, Pulmonary- Critical Care section; all at Central Texas Veterans Health Care System in Temple, Texas.
Correspondence: Gagan Prakash (gagan.prakash@va.gov)
Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article.
Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its
agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing
information for specific drugs or drug combinations—including
indications, contraindications, warnings, and adverse effects—
before administering pharmacologic therapy to patients.
As previously discussed, blood cultures are often negative with invasive candidiasis, as the window of opportunity is short and may be missed. As shown in murine models, it is easy to miss a narrow window of candidemia, leading to false-negative blood cultures in clinical practice.14,15 Mouse model studies also have found that the window of candidemia is very short in disseminated candidiasis as a lethal IV dose of C albicans disappeared from blood within 48 hours of postinoculation.15 The biomarker of serum procalcitonin is a great diagnostic resource for the elimination of a likely bacterial sepsis, and conversely, the early suspicion of a fungemia, as serum procalcitonin would typically be elevated in a bacterial but not a fungal septicemia.16 The average cost per test is only about $30, and we recommend testing for serum procalcitonin as well as monitoring of serum lactate levels in cases of nonresponding septicemia.
The C albicans in this case may have been introduced hematogenously from the amputation site or through an ascending cystitis, or possibly have been derived from commensal flora in the GI tract. The iron supplementation provided to the patient may have promoted the growth and virulence of the candida; studies have shown that the kidneys assimilate increased levels of iron during disseminated candidiasis thus providing a more favorable site for colonization.17The presence of C albicans in a single collection of sputum or urine does not ordinarily indicate infection in an immunocompetent individual. Estimation of serum procalcitonin, a biomarker for bacterial infection and sepsis, might be useful if negative, for turning attention to a nonbacterial (such as, candida) source as the causative agent.18
C albicans can rarely cause disseminated disease in nonimmunocompromised critically ill patients. Low serum procalcitonin levels in a septic patient might indicate nonbacterial cause such as candidiasis. Even with disseminated candidiasis, blood cultures may remain negative.
Early findings from the CARES study show clinical improvement and eradication of candidemia.
Examining a patient’s nails and understanding nail growth mechanics can provide helpful clues to help treat past injuries or underlying diseases...
Immune status, severity or burden of disease, appropriate dosing of medication, and drug resistance are important considerations when treating...